IBDEI130 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39270,2)
 ;;=^5063408
 ;;^UTILITY(U,$J,358.3,39271,0)
 ;;=Z85.21^^148^1948^91
 ;;^UTILITY(U,$J,358.3,39271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39271,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Larynx
 ;;^UTILITY(U,$J,358.3,39271,1,4,0)
 ;;=4^Z85.21
 ;;^UTILITY(U,$J,358.3,39271,2)
 ;;=^5063411
 ;;^UTILITY(U,$J,358.3,39272,0)
 ;;=Z85.3^^148^1948^85
 ;;^UTILITY(U,$J,358.3,39272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39272,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,39272,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,39272,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,39273,0)
 ;;=Z85.41^^148^1948^87
 ;;^UTILITY(U,$J,358.3,39273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39273,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,39273,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,39273,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,39274,0)
 ;;=Z85.43^^148^1948^95
 ;;^UTILITY(U,$J,358.3,39274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39274,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,39274,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,39274,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,39275,0)
 ;;=Z85.46^^148^1948^96
 ;;^UTILITY(U,$J,358.3,39275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39275,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,39275,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,39275,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,39276,0)
 ;;=Z85.47^^148^1948^100
 ;;^UTILITY(U,$J,358.3,39276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39276,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,39276,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,39276,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,39277,0)
 ;;=Z85.51^^148^1948^84
 ;;^UTILITY(U,$J,358.3,39277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39277,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bladder
 ;;^UTILITY(U,$J,358.3,39277,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,39277,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,39278,0)
 ;;=Z85.528^^148^1948^89
 ;;^UTILITY(U,$J,358.3,39278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39278,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,39278,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,39278,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,39279,0)
 ;;=Z85.6^^148^1948^80
 ;;^UTILITY(U,$J,358.3,39279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39279,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,39279,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,39279,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,39280,0)
 ;;=Z85.72^^148^1948^104
 ;;^UTILITY(U,$J,358.3,39280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39280,1,3,0)
 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
 ;;^UTILITY(U,$J,358.3,39280,1,4,0)
 ;;=4^Z85.72
 ;;^UTILITY(U,$J,358.3,39280,2)
 ;;=^5063436
 ;;^UTILITY(U,$J,358.3,39281,0)
 ;;=Z85.79^^148^1948^94
 ;;^UTILITY(U,$J,358.3,39281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39281,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
 ;;^UTILITY(U,$J,358.3,39281,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,39281,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,39282,0)
 ;;=Z85.820^^148^1948^83
 ;;^UTILITY(U,$J,358.3,39282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39282,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,39282,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,39282,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,39283,0)
 ;;=Z85.828^^148^1948^98
 ;;^UTILITY(U,$J,358.3,39283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39283,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,39283,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,39283,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,39284,0)
 ;;=Z85.71^^148^1948^78
 ;;^UTILITY(U,$J,358.3,39284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39284,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,39284,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,39284,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,39285,0)
 ;;=Z65.8^^148^1948^138
 ;;^UTILITY(U,$J,358.3,39285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39285,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,39285,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,39285,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,39286,0)
 ;;=Z86.11^^148^1948^115
 ;;^UTILITY(U,$J,358.3,39286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39286,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,39286,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,39286,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,39287,0)
 ;;=Z86.13^^148^1948^82
 ;;^UTILITY(U,$J,358.3,39287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39287,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,39287,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,39287,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,39288,0)
 ;;=Z86.73^^148^1948^112
 ;;^UTILITY(U,$J,358.3,39288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39288,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,39288,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,39288,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,39289,0)
 ;;=Z86.79^^148^1948^75
 ;;^UTILITY(U,$J,358.3,39289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39289,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,39289,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,39289,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,39290,0)
 ;;=Z91.040^^148^1948^64
 ;;^UTILITY(U,$J,358.3,39290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39290,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,39290,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,39290,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,39291,0)
 ;;=Z98.89^^148^1948^120
 ;;^UTILITY(U,$J,358.3,39291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39291,1,3,0)
 ;;=3^Postprocedural States/Hx of Surgery NEC
 ;;^UTILITY(U,$J,358.3,39291,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,39291,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,39292,0)
 ;;=Z92.3^^148^1948^79
 ;;^UTILITY(U,$J,358.3,39292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39292,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,39292,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,39292,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,39293,0)
 ;;=Z91.120^^148^1948^60
 ;;^UTILITY(U,$J,358.3,39293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39293,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,39293,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,39293,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,39294,0)
 ;;=Z91.11^^148^1948^69
 ;;^UTILITY(U,$J,358.3,39294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39294,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,39294,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,39294,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,39295,0)
 ;;=Z87.891^^148^1948^103
 ;;^UTILITY(U,$J,358.3,39295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39295,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,39295,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,39295,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,39296,0)
 ;;=Z77.090^^148^1948^11
 ;;^UTILITY(U,$J,358.3,39296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39296,1,3,0)
 ;;=3^Asbestos Contact/Exposure
 ;;^UTILITY(U,$J,358.3,39296,1,4,0)
 ;;=4^Z77.090
 ;;^UTILITY(U,$J,358.3,39296,2)
 ;;=^5063312
 ;;^UTILITY(U,$J,358.3,39297,0)
 ;;=Z57.8^^148^1948^72
 ;;^UTILITY(U,$J,358.3,39297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39297,1,3,0)
 ;;=3^Occupational Exposure to Other Risk Factors
 ;;^UTILITY(U,$J,358.3,39297,1,4,0)
 ;;=4^Z57.8
 ;;^UTILITY(U,$J,358.3,39297,2)
 ;;=^5063127
 ;;^UTILITY(U,$J,358.3,39298,0)
 ;;=Z77.21^^148^1948^53
 ;;^UTILITY(U,$J,358.3,39298,1,0)
 ;;=^358.31IA^4^2
